Investigating the mechanism of Jiawei Xiaoyao San in treating metabolic associated fatty liver disease (MAFLD) based on the ileal microbiota-bile acid-FXR axis

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 98c076b35e94cf9b-ATL IP: 118.31.43.22 UTC time: 2025-10-09T20:00:21+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4